Expression of ERCC 1 , MSH 2 and PARP 1 in Non-small Cell Lung Cancer and Prognostic Value in Patients Treated with Platinum-based Chemotherapy

@inproceedings{Xie2014ExpressionOE,
  title={Expression of ERCC 1 , MSH 2 and PARP 1 in Non-small Cell Lung Cancer and Prognostic Value in Patients Treated with Platinum-based Chemotherapy},
  author={K Xie and Hong-Er He and Ai-jing Sun and Xi-bo Liu and Li-Ping Sun and Xue-jun Dong},
  year={2014}
}
Lung cancer is one of the most common malignances, of which the occurrence and mortality is increasing every year due to air pollution, environmental breakdown and cigarette abuse (Jemal et al., 2005; 2006). Non-small cell lung cancer (NSCLC) is the main type of lung cancer, accounting for about 80-85%, and is the leading reason of death caused by lung cancer (Parkin et al., 2005). Surgical treatment is generally considered curative for early-stage NSCLC. However, more than 60% patients suffer… CONTINUE READING
2 Citations
28 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 28 references

Similar Papers

Loading similar papers…